ArticleCancer immunology, immunotherapy : CII2014

Combining trastuzumab and cetuximab combats trastuzumab-resistant gastric cancer by effective inhibition of EGFR/ErbB2 heterodimerization and signaling.

Lei Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.